Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.47 |
| ▸ | ADH1C | P00326 | 1/20 | 0.47 |
| ▸ | ADH1A | P07327 | 1/20 | 0.47 |
| ▸ | ADH4 | P08319 | 1/20 | 0.47 |
| ▸ | ADH7 | P40394 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7079201 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL8958561 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL11445208 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL7923014 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL8411738 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL9579563 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL7925024 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL4662691 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL19252728 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL8677317 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220193107-A1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | BONAFIDE HEALTH, LLC | 2022-06-23 | — | — | US | disclosed |
| US-20220031729-A1 | USE OF S-ADENOSYLMETHIONINE FOR PERSONALIZED TREATMENT OF DEPRESSION | Zentar LLC (US) | 2022-02-03 | — | — | US | disclosed |
| US-20200129537-A1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | MSI-195 HOLDINGS, LLC | 2020-04-30 | — | — | US | disclosed |
| US-20190022119-A1 | Compositions comprising S-Adenosylmethionine and a gallic acid ester | MSI-195 HOLDINGS, LLC | 2019-01-24 | — | — | US | disclosed |
| US-9925208-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2018-03-27 | — | — | US | disclosed |
| US-9801896-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2017-10-31 | — | — | US | disclosed |
| EP-3131557-A2 | NOVEL ADEMETIONINE FORMULATIONS | Methylation Sciences International SRL (BB) | 2017-02-22 | — | — | EP | disclosed |
| US-20170027976-A1 | NOVEL ADEMETIONINE FORMULATIONS | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2017-02-02 | — | — | US | disclosed |
| EP-2949331-A1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | Methylation Sciences International SRL (BB) | 2015-12-02 | — | — | EP | disclosed |
| WO-2015159155-A2 | NOVEL ADEMETIONINE FORMULATIONS | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2015-10-22 | — | — | WO | disclosed |
| US-20150164935-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BONAFIDE HEALTH, LLC | 2015-06-18 | — | — | US | disclosed |
| EP-2753336-B1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | METHYLATION SCIENCES INTERNAT SRL (BB) | 2015-05-06 | — | — | EP | disclosed |
| US-8975238-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2015-03-10 | — | — | US | disclosed |
| US-20140220129-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2014-08-07 | — | — | US | disclosed |
| CN-102224116-B | Use of polyols and cyclohexane polycarboxylic acid derivatives for the removal of dust from chemical construction products | CONSTR RES & TECH GMBH | 2014-07-02 | — | — | CN | disclosed |
| WO-2014059522-A1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2014-04-24 | — | — | WO | disclosed |
| US-6436890-B1 | Antimicrobial detergent composition | INUI CORPORATION (JP) | 2002-08-20 | — | — | US | disclosed |
| EP-0054139-B1 | BINDERS FOR COATINGS TO WORK UP OUT OF THE MOLTEN MASS, AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-05-30 | — | — | EP | disclosed |
| EP-0054139-A1 | Binders for coatings to work up out of the molten mass, and their use | BASF Aktiengesellschaft (DE) | 1982-06-23 | — | — | EP | disclosed |
| EP-0007531-A1 | Vinyl chloride copolymers containing carboxyl groups and use thereof | BASF Aktiengesellschaft (DE) | 1980-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193107-A1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | BHMT2, BHMT, MAT1A | ADH1B 141/4885ADH1C 839/4885ADH1A 271/4885 |
| US-20190022119-A1 | Compositions comprising S-Adenosylmethionine and a gallic acid ester | BHMT2, BHMT, MAT1A | ADH1B 141/4885ADH1C 839/4885ADH1A 271/4885 |
| US-20150164935-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BHMT2, BHMT, MAT1A | ADH1B 141/4885ADH1C 839/4885ADH1A 271/4885 |
| US-20200129537-A1 | COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER | BHMT2, BHMT, MAT1A | ADH1B 141/4885ADH1C 839/4885ADH1A 271/4885 |
| US-20220031729-A1 | USE OF S-ADENOSYLMETHIONINE FOR PERSONALIZED TREATMENT OF DEPRESSION | BHMT2, BHMT, MAT2A | ADH1B 243/4885ADH1C 1789/4885ADH1A 843/4885 |
| US-20170027976-A1 | NOVEL ADEMETIONINE FORMULATIONS | BHMT2, MAT1A, BHMT | ADH1B 35/4885ADH1C 151/4885ADH1A 48/4885 |
| US-20140220129-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BHMT2, BHMT, MAT1A | ADH1B 141/4885ADH1C 839/4885ADH1A 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.